@SaveChildrenIT@SaveIT_legale In Italia la maternità continua ad avere un costo sociale ed economico enorme per le donne.
Il rapporto “Le Equilibriste 2026” racconta precarietà, child penalty, welfare fragile e diseguaglianze territoriali.
Nel mio nuovo articolo l’analisi giuridica e costituzionale del fenomeno ⬇️
https://t.co/TdJOX9dnRH
#giornatamondialecontroilcancro
"Fiorire d’inverno" di Nadia Toffa, "Wondy" di Francesca Del Rosso e "Mi vivi dentro" di Alessandro Milan, tre libri autobiografici che raccontano la dura lotta contro il cancro.
Resta l' amore.
Elena Genero Santoro
https://t.co/NIcKPByLnL
🫂 When oncologists are the family members, the words hit differently. Filipe Coutinho, MD, reflects on navigating cancer not as a clinician, but as a loved one, and how it reshaped his approach to care.
✍️ @Dr_F_Coutinho
🔗 https://t.co/TouwVWj7c8
🚨 Big news from #EANO2025!
Final #CATNON results show adding 12 cycles of temozolomide after radiotherapy doubles survival in IDH-mutant anaplastic astrocytoma: 12.5 vs 6 years.
A global academic effort in rare cancers.
🔗Full story: https://t.co/b0YtBpHeEk
@EANOassociation
📢 @EANOassociation 2025 kicks off today in Prague!
Proud to see strong #EORTC representation with six abstracts and a joint session with BTG featuring EORTC-led projects on clinical trial planning.
More info 👉 https://t.co/KQmVoNDQHP
#EANO2025#NeuroOncology#CancerResearch
Oggi ho concluso il #dottorato.
Un capitolo rimasto aperto durante momenti intensi ma anche difficili.
Eppure grata, perché è stato il periodo in cui ho accolto Giacomo nella mia vita.
E avanti.
Today I completed my #PhD.
A chapter that had stayed open through intense but also difficult times.
Yet I am grateful, because during this period, little Giacomo came into my life.
Let's move forward.
3 inspiring lectures at the Masterclass in #Neuroncology @ Padova
📍 Longitudinal sampling: a new frontier in GBM treatment – @EAChiocca
📍 Overcoming, bypassing & disrupting the BBB – Ahmed Idbahi
📍 A bridge over troubled waters: making vaccines work in GBM – David Reardon
Final Update CATNON ASCO 2025
· Median F/U 11 yrs
· NO sig benefit concurrent TMZ
· Sig benefit (HR 0.54) Adjuvant TMZ in IDHm (median OS 12.5 years)
· NO benefit w/TMZ for IDHwt
We are grateful to our ~44,000 attendees who made #ASCO25 a success & the place to be! With nearly 40% joining us from outside the U.S., we are truly a global community united by our shared goal of improving #CancerCare & pt outcomes around the world. A heartfelt ‘thank you.’ 💗
Bispecific antibodies, which can target 2 antigens or pathways at once, are being used more frequently in cancer care. An Ed Session later this morning at #ASCO25 (11:30AM, Rm S406) will discuss their role in treatment + potential adverse events: https://t.co/QVv9FMtsXN @curijoey
Congratulations to the 2025 ASCO Annual Meeting Merit Award and Special Merit Award recipients. These awards will support 137 students and trainees who are first authors on abstracts selected for presentation at #ASCO25. View the full list of recipients: https://t.co/CWLUxr2cVA
Ti ho visto "pellegrino penitente" nell'#Iraq a cui nessuno prima di te, incolpevole, aveva chiesto scusa. E tra i profughi di #Lesbo. Te ne vai nel momento in cui abbiamo più bisogno. Chi chiamerà tutte le sere #Gaza?
Senza meritarlo, seguiremo il tuo esempio
#PapaFrancesco